Kymera Therapeutics to Participate in Upcoming June Investor Conferences
Kymera Therapeutics to Participate in Upcoming June Investor Conferences GlobeNewswire May 29, 2025 WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the […]